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To examine transcription factor (TF) network(s), we
created mouse ESC lines, in each of which 1 of 50
TFs tagged with a FLAG moiety is inserted into
a ubiquitously controllable tetracycline-repressible
locus. Of the 50 TFs, Cdx2 provoked the most exten-
sive transcriptome perturbation in ESCs, followed by
Esx1, Sox9, Tcf3,Klf4, andGata3. ChIP-Seq revealed
that CDX2 binds to promoters of upregulated target
genes. By contrast, genes downregulated by CDX2
did not show CDX2 binding but were enriched with
binding sites for POU5F1, SOX2, and NANOG. Genes
with binding sites for these core TFswere also down-
regulated by the induction of at least 15 other TFs,
suggesting a common initial step for ESC differentia-
tionmediated by interferencewith the binding of core
TFs to their target genes. These ESC lines provide
a fundamental resource to study biological networks
in ESCs and mice.
INTRODUCTION
The prevailing paradigm of modern biology states that gene
regulatory networks determine the identity of cells, and that their
alteration by environmental factors dictates changes of cell iden-
tity, i.e., cell differentiation (Davidson, 2006). Analysis of the
structure and dynamics of gene regulatory networks is key to
the understanding of biological systems but poses a great chal-
lenge because of the vast and manifold complexity of regulatory
mechanisms.
One possible approach is to carry out a systematic gene
perturbation study in order to ‘‘reverse engineer’’ these regula-
tory networks. Ideally, all the transcription factors would be
manipulated one at a time and in different combinations in
a variety of cell types. Readout of the impact of such manipula-
tion would be monitored in a variety of ways, including the420 Cell Stem Cell 5, 420–433, October 2, 2009 ª2009 Elsevier Inc.profiling of all RNA transcripts and proteins. This type of
approach is complementary to conventional studies in which
systematic gene manipulations have been successfully carried
out, but usually with a focus on the phenotype, e.g., cell
morphology, growth property, and differentiation markers
(Chambers et al., 2003; Ivanova et al., 2006; Pritsker et al.,
2006). To this end, mouse ESCs (Evans and Kaufman, 1981;
Martin, 1981) are most suitable, because they can be differenti-
ated into a variety of cell types in distinct cell culture conditions
in vitro (Murry and Keller, 2008) and can also be developed into
animal models to further study the effects of gene perturbation
in vivo (Solter, 2006). As a complementary approach to the
comprehensive loss-of-function study of all mouse genes
(Collins et al., 2007; Skarnes et al., 2004), we aim to generate
ESC lines in which a TF can be induced for gain of function in
a controlled manner, enabling observations of the network
perturbation caused by each TF in a uniform condition across
all the ESC lines.
Global gene regulatory networks have been intensively
studied in mouse ESCs by expression profiling (Walker et al.,
2007), protein complex analysis (Wang et al., 2006), and
genome-wide chromatin immunoprecipitation (Loh et al.,
2006). The critical roles of three transcription factors—Pou5f1
(Oct4 or Oct3/4) (Nichols et al., 1998), Sox2 (Yuan et al., 1995),
and Nanog (Chambers et al., 2003; Mitsui et al., 2003)—discov-
ered earlier (reviewed in Niwa, 2007; Silva and Smith, 2008) have
recently been rationalized by the discovery of core transcrip-
tional regulatory networks between these genes (Boyer et al.,
2005; Loh et al., 2006). Furthermore, similar analyses of other
key TFs in mouse ESCs have successfully extended the core
transcriptional network (Chen et al., 2008; Kim et al., 2008). Obvi-
ously, the analysis of many more TFs, including genes that are
not expressed in ESCs, is required to explore global TF
network(s) that may be outside of the core transcriptional
network of Pou5f1, Sox2, andNanog. To this end, an appropriate
mouse embryonic stem cell bank could facilitate a variety of
high-throughput, genome-wide analysis methodologies.
Here we describe a strategy for and the establishment of
TF-inducible ESC lines, and we show how these ESC lines can
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we characterize how an exemplary differentiation-inducing TF,
Cdx2, regulates the global transcriptome and shifts the balance
of gene regulatory network toward ESC differentiation.
RESULTS
Generation and Quality Control of Transcription
Factor-Inducible Mouse ESC Lines
We analyzed 50 TF genes (3% of all 1600–2000 TFs encoded in
the mouse genome; Kanamori et al., 2004; Messina et al., 2004)
to assess the consequences of their induction in ESCs. These
genes were selected primarily from a set of high-priority genes
involved in critical functions in mouse ESCs and their differenti-
ation, inferred in our previous work (Matoba et al., 2006). About
half the genes are expressed in undifferentiated ESCs; the other
half are not expressed or are expressed at a low level in undiffer-
entiated ESCs but are induced in differentiating ESCs. We also
included genes expressed late in lineage specification (Ascl1,
Ascl2, Myod1, Sox9, and Sfpi1) to see whether TFs can induce
their cognate targets without their usual regulatory context for
function. Three non-TF genes—Dppa5a, Gadd45a, and
Tuba1a—and one empty vector were included as controls. A
total of 53 genes and a control used for this work are listed in
Figure 1A. To induce a specific TF, we employed the Tet-repress-
ible gene expression system, with the expression cassette inte-
grated at the ROSA26 locus (ROSA-TET locus) (Figure 1B;
Figure S1A available online; Masui et al., 2005). This system
makes use of the ubiquitous and relatively high expression at
the ROSA26 locus (Soriano, 1999). In the absence of doxycycline
(Dox), the recombinant ROSA-TET locus expresses a polycis-
tronic transcript for the open reading frame (ORF) of TF and
Venus YFP proteins. To facilitate the detailed analyses of indi-
vidual TFs, we inserted a FLAG tag at the C terminus of all trans-
genes, making it possible to use FLAG as a universal bait for
immunological assays. In order to minimize clone-to-clone vari-
ation of gene expression level and to generate these ESCs as
a permanent resource for future work, we synchronized passage
numbers and performed multistep quality control of these ESCs
(Figures 1B, 1F, and 1G; Supplemental Data).
Dox Inducibility of the Transgene in Each
of 54 ESC Lines
We first carried out control experiments and found that three
medium changes at 3 hr intervals minimized unwanted perturba-
tion associated with commonly used cell passaging while
inducing the transgene fully by effectively removing Dox
(Figure S2). Indeed, the control ESCs, in which an expression
unit without an ORF was inserted into the ROSA-TET locus,
showed only a small number of genes differentially expressed
(see below). In all transgene induction experiments, we set the
last medium change as 0 hr induction.
We also carried out time course DNA microarray analysis of 10
ESC lines (Figure S3) and time course western blot analysis of 17
ESC lines (Figure 1D; Figure S4). Western blots showed that in all
examined cases, a transgene-derived protein started to appear
by 12 hr after induction and reached a maximum level by
48 hr. DNA microarray analysis showed that whereas the global
transcriptome began to change within 24 hr, the expression ofthe majority of genes changed relatively monotonically until
72 hr (Figure S3). To capture early effects of TF induction, we
looked 48 hr after induction for the expression profiling of all
54 ESC lines in the Dox+ and Dox conditions. Except for Dox,
all other culture conditions (including LIF) were the same in
both Dox+ and Dox conditions. We confirmed that each trans-
gene expressed a protein that was detectable by an antibody
against the FLAG tag by western blot and immunohistochemistry
(Figures 1D and 1E; Figures S4 and S5). Immunohistochemistry
also showed that TF proteins are mainly localized in the nucleus
(Figure 1E; Figure S5). The induced level of a transgene was
comparable among ESC lines based on the measurement of
transcript levels via qRT-PCR (Figure 1C; Figure S6A). To assess
the induced level of TFs at the protein level, we also carried out
western blot analysis with native antibodies that detect both
endogenous and exogenous TFs. As expected for TFs that are
already expressed in ESCs, we detected only mild (up to 2- to
3-fold) increases in TF levels (Figures S4C and S4D). For
example, the amount of STAT3 protein was induced by
2.7-fold, which was only 3.4-fold higher than that in thymus
(Figure S4D). In contrast, CDX2, which is not usually expressed
in ESCs, showed an 80-fold increase, but was only 2-fold
higher than the highest protein level reached in the differentiated
trophoblast cells (Figure S4D). These data indicate that the
induced levels of TFs in this system are largely within the physi-
ological range of gene dosage.
Global Patterns of Gene Expression in Response
to Induction of TFs
To assess the extent of changes in global gene expression
patterns, we first combined all the new microarray data obtained
from 54 ESC lines with previous microarray data that we had ob-
tained from ESCs differentiating into three cell lineages (Aiba
et al., 2009). The data sets were fully compatible because the
same microarray platform was used. Principal component anal-
ysis (PCA) of all 304 microarray data sets revealed that the tran-
scriptome state of all the TF-inducible ESCs, even after 48 hr of
TF induction (Dox), did not shift away from the zone where
undifferentiated pluripotent ESCs were clustered (Figure 2A;
see Table S1 for data on expression changes for all genes).
This indicates that transcriptome changes measured 48 hr after
TF induction reflect the early effects of the TF in undifferentiated
or nearly undifferentiated ESCs, but not in more differentiated
cell types. Consistent with the PCA, most of the TF-induced
ESCs showed no significant morphological changes at 48 hr
(data not shown). However, after 7 days of continuous induction
of TFs, most of the examined ESC lines showed morphological
changes indicative of differentiation (Figure S7).
Interestingly, even these early effects of transcriptome
changes often revealed incipient trajectories of differentiation,
as shown as clusters in the ‘‘heatmap’’ (Figure 2B; see Table S2
for data of individual genes). This became more evident when
these expression profiles were compared to the microarray
data of ESCs differentiating into specific lineages (Aiba et al.,
2009) and those of mature tissues and organs (Su et al., 2002).
For example, ESC lines with Sox2, Pou5f1, Nrip1, and Ascl1
showed the greatest similarity to epiblast/neural cells; ESC lines
with Ascl2, Cdx2, Eomes, and Esx1 showed the greatest simi-
larity to trophoblast cells; and ESC lines with Gata3 showedCell Stem Cell 5, 420–433, October 2, 2009 ª2009 Elsevier Inc. 421
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(A) List of ESC lines generated and analyzed in this study.
(B) Schematic diagram for the strategy. A parental ESC line was named ES[MC1R(20)], which stands for MC1 ESCs, ROSA-TET locus [R], and clone number 20.
Each ESC line was named by adding the name of a transgene and the clone number. For example, the ESC line that was generated by integrating the Aes gene
was named ES[MC1R(20):tetAes(24)]. For brevity, ESC lines are simply referred by the name of a transgene (e.g., Aes) throughout the text and figures.
(C–G) Representative results for quality control of the ESC line ES[MC1R(20):tetNr5a2(7)].
(C) qRT-PCR analysis of transcript levels of the ESCs cultured for 48 hr in the presence (+) or absence () of doxycycline: (left) transcripts measured by a primer
pair for ORF (both endogenous and transgene Nr5a2); (middle) transcripts measured by endogenous Nr5a2-specific primer pair; (right) transcripts measured by
a primer pair for Venus (representing a transgene). Values are shown as fold-induction compared with Dox+ condition. Data are presented as means ± SEM.
(D) Time-course analysis of exogenous (i.e., a transgene-derived) NR5A2 protein expression by western blotting with an antibody against FLAG (top) and b-actin
(bottom).
(E) Localization of the exogenous NR5A2 protein by immunostaining with FLAG antibody (left) and localization of Venus fluorescence (middle) and DNA (right).
(F) Karyotypes of ES[MC1R(20):tetNr5a2(7)] showing 88% euploidy.
(G) A representative picture of the metaphase spread. See Supplemental Experimental Procedures for information on other clones.422 Cell Stem Cell 5, 420–433, October 2, 2009 ª2009 Elsevier Inc.
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TF-Inducible ESC Lines
(A) Principal component analysis (PCA) of gene
expression profiles of 152 different cell types: 54
TF-inducible ES lines with induced overexpression
of various TFs (48 hr in Dox, marked red), the
same 54 TF-inducible ES lines (48 hr in Dox+,
marked red), and 44 different cell types, which
represent ESCs differentiating into three cell line-
ages (trophoblast, primitive endoderm [PE], and
neural, marked blue, green, and yellow, respec-
tively). All cell lines with induced TFs show gene
expression profiles (encircled) very similar to that
of undifferentiated ESCs, although a few TFs
caused some changes toward differentiation
(shown by arrows). The explanation of PCA and
the details of these 44 cell types are given in the
previous publication (Aiba et al., 2009). Only repre-
sentative cell types are labeled: Klf4 (Dox), Sox9
(Dox), Tcf3 (Dox), Cdx2 (Dox), and Eomes
(Dox). The trophoblast lineage is represented by
Z0–Z5 (ESCs differentiating into trophoblast cells
from day 0 to day 5 after repressing Pou5f1
expression), TS (trophoblast stem cells), and PL
(E13.5 placenta). The PE lineage is represented
by F0–F5 (embryonal carcinoma cells differenti-
ating into primitive endoderm from day 0 to day
5). The neural lineage is represented by N2–N6
(ESCs differentiating into neural lineage from day
2 to day 6), P0–P4 (embryonal carcinoma cells
differentiating into neural cells), NS (neural stem/
progenitor cells), and DC (differentiated neuron
and glia). 3T, NIH 3T3 fibroblast cells; MB, mouse
embryo fibroblast cells.
(B) A heatmap showing the results of hierarchical
clustering analysis of all the microarray data (54
ESC lines). Only the top 3000 genes whose
expression are most significantly altered are
used for the analysis. Both genes and ESC lines
are clustered according to their similarity of global
gene expression patterns measured by Pearson
correlation of log-transformed expression values.
The list of genes and their expression change for
this heatmap is given in Table S2.
(C and D) Significance of correlations between
gene expression response to the induction of
TFs in TF-inducible ESC lines (data from this
paper) and gene expression in published data
sets (Aiba et al., 2009; Su et al., 2002). Gene
expression in published data sets was log-trans-
formed and centered; the mean value was sub-
tracted for each gene.
(C) Cell types in the data set for trajectories of early
lineage differentiation (Aiba et al., 2009): Extraembryonic (TS, PL); trophoblast (Z2–Z5); fibroblasts (3T, MB, MD, ST); primitive endoderm (F2–F5, G1–G5); neural/
primitive ectoderm (N2–N6, NS, DC); and other (E1–E5, EG, F0, F1, G0, IF, IN, N0, N1, P0, P4, TG, Z0, Z1).
(D) Tissues in the GNF database (Su et al., 2002): placenta; heart and muscles (skeletal); lymph node, thymus, immune (B220+ B cells, CD4+ T cells, CD8+ T cells);
umbilical cord, uterus; blastocyst; and other (adipose tissue, adrenal gland, amygdala, bladder, bone, bone marrow, brown fat, cerebellum, cerebral cortex,
digits, dorsal root ganglia, dorsal striatum, embryo day 10.5, embryo day 6.5, embryo day 7.5, embryo day 8.5, embryo day 9.5, epidermis, eye, fertilized
egg, frontal cortex, hippocampus, hypothalamus, kidney, large intestine, liver, lung, mammary gland [lact], medial olfactory epithelium, olfactory bulb, oocyte,
ovary, pancreas, pituitary, preoptic, prostate, salivary gland, small intestine, snout epidermis, spinal cord lower, spinal cord upper, spleen, stomach, substantia
nigra, testis, thyroid, tongue, trachea, trigeminal, vomeralnasal organ).the greatest similarity to primitive endoderm cells (Figure 2C).
Similarly, even TFs that are known to function in late lineage
specification induced expression profiles that correspond to
those late-stage differentiated cells. For example, ESCs withMyod1 and Mef2c showed the greatest similarity to heart and
muscle tissues, and ESCs with Sfpi1 showed the greatest simi-
larity to lymph node, thymus, and immune cells (Figure 2D).
The results were generally consistent with previously publishedCell Stem Cell 5, 420–433, October 2, 2009 ª2009 Elsevier Inc. 423
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Systems Biology of ESCsFigure 3. Extent of Transcriptome Perturbation by TFs and Pair-wise Comparison of Expression Changes
(A) Scatter-plots comparing expression profiles of representative ESC lines between Dox+ and Dox conditions. Red spots represent genes that show higher than
2-fold expression (upregulated) and green spots represent genes that show lower than 2-fold expression (downregulated) in Dox condition than in Dox+ condi-
tion with statistical significance of FDR < 0.05. The number of up- and downregulated genes are also shown.
(B) The number of genes whose expression was affected significantly (FDR < 0.05 and expression changes > 2-fold) by induction of various TFs in ESCs. ESC lines
are ordered according to the expression levels of endogenous TF gene in undifferentiated ESCs based on published RNA-Seq data (Table S11; Cloonan et al.,
2008).functions of these TFs: Cdx2, Esx1, Ascl2, and Eomes (Simmons
and Cross, 2005); Sox2 and Ascl1 (Diez del Corral and Storey,
2001); and Myod1 and Mef2c (Naya and Olson, 1999).
Next, genes whose expression was affected by induction of
TFs were identified via pair-wise statistical comparison (FDR <
0.05 and expression changes > 2-fold) between microarray
data for the same clone in Dox+ and Dox conditions
(Figure 3A; Figures S6B and S8). Some TFs (e.g., Cdx2, Esx1,
Gata3, Klf4, Sox9, and Tcf3) caused substantial changes in the
transcriptome, whereas other TFs (e.g., Fem1b and Cbx8) had
little effect (Figure 3B; Tables S3 and S4). For the most part,
induction of TFs that were already present in ESCs (ESC lines
on the left side of Figure 3B) had a smaller effect on the gene
expression profile than induction of differentiation-related genes
that have low endogenous expression in ESCs (ESC lines on the
right side of Figure 3B). It seems reasonable that the greater the
fold-induction of a TF, the greater the global perturbation of tran-
scriptome. However, induction of Klf4 and Sox2 (and to some
extent Pou5f1) resulted in a strong response even though they
were already expressed in ESCs and thus showed low fold-
induction of their expression levels, indicating that these TFs
have an unusually dose-sensitive and potent regulatory role.
Dissecting Gene Regulatory Networks:
The Example of Cdx2
As a proof of principle for the utility of the ESC lines, we report our
study of Caudal type homeobox 2 (Cdx2), which was selected
because of its exceptionally strong effect on the transcriptome424 Cell Stem Cell 5, 420–433, October 2, 2009 ª2009 Elsevier Inc.(Figure 3B) and its unique role in mouse embryo development.
Cdx2 is the earliest differentiation marker in the embryo and
is highly expressed in the trophectoderm lineage (Strumpf
et al., 2005), and the balance between Pou5f1 and Cdx2
expression shifts cell fate during preimplantation development
(Niwa et al., 2005).
Time course western blot analysis showed that the product of
the transgene (CDX2-FLAG) was induced to a high level within
0.5 days after removal of Dox, reaching a maximum by 48 hr
and remaining very high until day 5, with a slight reduction by
day 7 (Figure 4A). Antibodies against CDX2, which recognize
both endogenous and exogenous CDX2, showed similar expres-
sion patterns (Figure 4A). Colony formation assays followed by
alkaline phosphatase staining showed that ESCs and colonies
became very flat and lost alkaline phosphatase staining, indi-
cating that Cdx2 induction alone caused differentiation of
ESCs by day 7 of induction (Figure 4B). Differentiation of
the Cdx2-inducible ESC line to trophoblast cells was confirmed
by positive immunostaining with trophoblast markers CDC42
(Natale and Watson, 2002) and ITGA7 (Klaffky et al., 2001)
(Figure 4C). These data are thus consistent with the previous
report of the induction of trophoblast cells from ESCs by Cdx2
overexpression (Niwa et al., 2005). Taken together, these data
confirm that transgene Cdx2-FLAG was induced by Dox, was
translated properly, and was functional as CDX2 protein.
Based on the DNA microarray analysis, 2090 genes were
upregulated and 1699 were downregulated by 48 hr of Cdx2
induction (Figure 3A). These genes include not only direct targets
Cell Stem Cell
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(A) Time-course analysis of CDX2 protein expression by western blotting (day 0, 0.5, 1, 2, 3, 5, and 7 after removal of Dox). Antibody against CDX2 protein recog-
nizes both endogenous and exogenous (i.e., transgene-derived) CDX2 protein. Antibody against FLAG recognizes only exogenous CDX2 protein. Antibody
against ACTB is used for the loading control.
(B) Alkaline phosphatase activity was tested in Cdx2 overexpressing (bottom) and control (top) cells with or without Dox for 6 days in culture (over view, left;
magnified, right).
(C) Cdx2-overexpressing cells induce trophectoderm markers CDC42 (top) and integrin alpha 7 (ITGA7; bottom) by 6 days.of CDX2, but also indirect targets that are regulated by the direct
targets. To identify direct targets of CDX2 at the genomic level,
we applied ChIP-Seq to Cdx2-inducible ESCs 48–60 hr after
induction. At this time, the ESCs did not yet show signs of differ-
entiation; thus, the ChIP-Seq results reflect Cdx2 function at the
very start of ESC differentiation. ChIP-western confirmed that
FLAG-IP pulled down cross-linked DNA-CDX2 protein
complexes in the Dox condition (Figure 5A). Sequencing of
FLAG-ChIP DNAs produced 17.59 million 36-nucleotide tags
that were mapped to the latest mouse genome sequence
(mm9, NCBI/NIH). We found that 5.72 million tags matched to
the genome with %2 nucleotide mismatches; the remaining
tags either did not match to the genome or matched to more
than 5 different locations. We found a total of 59,098 peaks
with at least 6 tags (Table S5), of which 15,855 had at least 10
tags. Significant peaks of tags (>9) were observed at 3152 loci
(genes) within 15 kb upstream and downstream of the transcrip-
tion start sites (TSS) (Table S6). However, only 38 genes had
peaks in the promoter regions (<300 bp upstream or down-
stream from the TSS), which indicates that CDX2 binds mostly
to more distant regulatory regions (300–15,000 bp upstream or
downstream of the TSS). Figure 5B shows a typical example of
peaks. Analysis of the CDX2-ChIP target sequence by CisFinder
software (Sharov and Ko, 2009; available at http://lgsun.grc.nia.
nih.gov/CisFinder/) indeed identified one main motif and five
additional variant motifs (Figure 5C). CDX2 binds mainly to
a [T/C][A/C]ATAAA[A/G] motif and to its direct repeat (Figure 5D).
The major motif matched the CDX2-binding motif identified by
direct binding in an oligonucleotide assay (Berger et al., 2008).
It is conceivable that some binding sites of TF may not be
involved in the regulation of gene expression. Therefore, we
used our recently published approach to identify ‘‘functional’’
direct targets of TF by combining TF binding information from
ChIP-Seq and gene expression changes caused by TF induction
(Sharov et al., 2008). The method compares binding score distri-
butions in genes that responded to TF manipulation with those in
control genes that did not respond to TF manipulation (see
details in Supplemental Experimental Procedures, Table S7).
Of the 3152 genes with CDX2-binding sites, the analysis re-
vealed a total of 337 functional target genes that satisfied statis-tical criteria (p < 0.1 and FDR < 0.6) (Table S8). Of these genes,
334 were upregulated after the induction of Cdx2 gene, and
only 3 were downregulated. Functional CDX2-target genes
included Hox genes and other differentiation-associated genes,
consistent with CDX2 function as an inducer of ESC differentia-
tion (Figure 5E; Table S8). The GO annotations of CDX2 target
genes are also available (Table S9). Selected target genes
were also further validated by ChIP-qPCR (Figure 5F). Consis-
tent with the ChIP-Seq data, we observed notably high enrich-
ment of CDX2 at promoter regions of Hox genes by ChIP-
qPCR validation (Figure 5F).
To see the correlation between the up- or downregulated
genes and CDX2-binding sites, we ranked all 25,030 genes ac-
cording to the changes caused byCdx2 induction and estimated
the proportion of genes with CDX2-binding sites in a sliding
window of 500 genes (Figure 5G; Tables S6 and S7). Interest-
ingly, genes upregulated after Cdx2 induction were strongly en-
riched in genes with CDX2 binding, but no enrichment was
observed among downregulated genes. This implies that upre-
gulation (i.e., positive regulation) of downstream genes is medi-
ated by direct binding of CDX2, whereas downregulation of
downstream genes is not. To gain further insights into a possible
mechanism for downregulation by CDX2, we used published
ChIP-Seq data for 13 TFs (Table S10; Chen et al., 2008). For
each TF, we estimated the proportion of genes with its binding
sites in their distal regulatory regions among genes that were
up- or downregulated by CDX2 and compared this with the
proportion of genes with binding sites among ‘‘control’’ genes
unresponsive to CDX2 (response < 1.25-fold). Strikingly, a list
of genes downregulated by the induction of Cdx2 was enriched
in genes that carry binding sites for POU5F1, SOX2, NANOG,
STAT3, and SMAD1 (Figure 5H). Because it is known that
POU5F1, SOX2, and NANOG form a core transcriptional network
(Boyer et al., 2005; Chen et al., 2008; Jaenisch and Young, 2008;
Kim et al., 2008; Loh et al., 2006), we tentatively call them, as
a group, pluripotency-associated transcription factors (pTFs).
When we plotted the proportion of genes with binding sites of
at least two pTFs against the changes of expression caused by
Cdx2 induction (Figure 5G; Table S7), we found that genes
downregulated after Cdx2 induction were strongly enriched inCell Stem Cell 5, 420–433, October 2, 2009 ª2009 Elsevier Inc. 425
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(A) Chromatins were prepared from Cdx2-inducible ESCs cultured for 48–60 hr in the Dox+ and Dox conditions. Chromatin immunoprecipitation (ChIP)
was carried out by using anti-FLAG M2 affinity gel. ChIP product was tested by western blotting with FLAG antibody. Nuclear extract from ESCs cultured for
48–60 hr in Dox+ and Dox condition was used for the western blot.
(B) CDX2 ChIP-Seq peaks in the Hoxa7 gene region. UCSC Mouse Mm9 browser view of Hoxa7 gene locus after mapping CDX2 ChIP-Seq tags locations in the
wiggle format. CDX2 ChIP-Seq peaks are shown in red.
(C) CDX2-binding motifs identified with CisFinder via 200 bp sequences centered at ChIP sites.
(D) Overrepresentation of CDX2 binding motifs in ChIP sites. Genomic sequences (2000 bp) centered at CDX2 binding sites found by ChIP-seq were extracted
from the genome and searched for the occurrence of CDX2 motifs. Binding motif was characterized by the position-frequency matrix (PFM) generated with Cis-
Finder software (see the text). Motif fit was evaluated by log-likelihood method assuming false positive rate of 1 per 10 Kb of a random sequence.
426 Cell Stem Cell 5, 420–433, October 2, 2009 ª2009 Elsevier Inc.
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Systems Biology of ESCsFigure 6. Analysis of the CDX2 Protein Complex Pulled down by FLAG Immunoprecipitation
(A) Confirmation of immunoprecipitation with FLAG antibody. Immunoprecipitates and nuclear extract were used for western blotting with FLAG antibody.
(B) A silver-stained SDS gel showing the presence of CDX2 major band and other distinct bands. Anti-FLAG M2 affinity gel was used for IP of CDX2 protein
complex from Cdx2-inducible ESCs. Nuclear extracts were prepared from Cdx2-inducible ESCs cultured for 48–60 hr in the Dox+ and Dox condition. Some
bands are marked with protein names identified by the mass spectrometry of the IP products. M, markers.
(C) Mass-spectrometry result was verified by IP-western assay. Anti-FLAG M2 affinity gel was used to immunoprecipitate (IP) CDX2 protein complex from the
nuclear extracts from Cdx2-inducible ESCs cultured for 48–60 hr in the Dox+ and Dox conditions. IP products were tested by western blotting with antibodies
against FLAG, KPNB1, HDAC1, and SALL4. Antibody against UBF was used as a control.
(D) Reverse IP carried out with antibodies against either HDAC1 or SALL4. IP products were tested by western blotting with antibodies against FLAG, HDAC1,
SALL4, and UBF. Nuclear extracts were also used as controls. Control UBF was detected in HDAC-IP sample as reported previously, but not detected in the
SALL4-IP sample.genes with pTF binding, but no enrichment was observed among
upregulated genes.
We initially considered that CDX2 might first downregulate
transcription of Pou5f1, Sox2, or Nanog, in turn resulting in the
reduction of either POU5F1, SOX2, or NANOG protein, and
consequently the downregulation of pTF-target genes. However,
ChIP-Seq data showed that CDX2 did not bind to enhancer/
promoters of Pou5f1, Sox2, and Nanog. Furthermore, when we
tested the protein level of these TFs with time course western
blot analysis of POU5F1, SOX2, and NANOG after CDX2 induc-
tion in ESCs, we found that the levels of POU5F1, SOX2, and
NANOG protein did not change by day 2, when pTF-target genes
were already significantly downregulated (Figure 5I, microarray
data). These findings make it unlikely that CDX2 first downregu-
lated Pou5f1, Sox2, and Nanog, leading to subsequent downre-
gulation of pTF-target genes. Instead, CDX2 seems to interfere
with the binding of POU5F1, SOX2, and/or NANOG to en-
hancers/promoters of their target genes. To further investigate
this possibility, we selected Pou5f1 as an example and carriedout ChIP-qPCR analysis of POU5F1-target genes by using
POU5F1 antibody in Cdx2-inducible ESCs in the Dox+ (i.e., in
the absence of CDX2) or in the Dox (i.e., in the presence of
CDX2) conditions (Figure 5J). The results indeed showed that
the induction of CDX2 caused reduced binding of POU5F1 to
its target sequence in downstream genes (Lef1, Tdgf1, Sox2,
Nanog, and to some extent, Pou5f1 itself) (Figure 5J). Taken
together, the data strongly suggest that CDX2 upregulates direct
target genes by directly binding to their regulatory regions, but
downregulates genes by interfering with the binding of pTFs to
the regulatory regions of pTF-target genes.
To investigate a possible mechanism by which CDX2 might
interfere with the binding of pTFs to their target genes, we
used a FLAG antibody to isolate a putative protein complex
from the Cdx2-manipulated ESCs 48–60 hr after CDX2 induction
(Dox) (Figure 6A). A silver-stained SDS-PAGE gel showed
a series of discrete bands that were not observed in a control
sample isolated from the Cdx2-manipulated ESCs in Dox+
conditions (Figure 6B). The silver-stained gel also indicated(E) Functional CDX2-target genes.
(F) Cdx2 ChIP-Seq result was verified by qPCR. Primers flanking a promoter region of Hbb-b1 and Pou5f1 as well as a gene desert region in chromosome 3 were
used as negative controls. Primers flanking of Actb gene promoter were used for normalization. The relative enrichment of CDX2 binding was indicated as fold
change. Error bars: ±SEM.
(G) Blue line: Relationship between gene expression changes caused by Cdx2 induction (x axis) and the proportion of genes with CDX2 binding sites identified with
a sliding window of 500 genes (y axis). Red line: Relationship between gene expression changes caused by Cdx2 induction (x axis) and the proportion of genes with
pTF binding sites identified with a sliding window of 500 genes (y axis) (more than two TFs out of POU5F1, SOX2, NANOG, STAT3, and SMAD1; data from H).
(H) Enrichment of genes with binding sites for each of 14 TFs among genes whose expression was upregulated or downregulated by the induction of Cdx2. The
enrichment was measured as a log ratio (log10) of the proportion of genes with binding sites among sets of genes that were upregulated (or downregulated) by >2-
fold and the proportion of genes with binding sites among the set of control genes that changed <1.25-fold. The error bar corresponds to the standard error (SE) of
the log ratio.
(I) Time course analysis of endogenous POU5F1, SOX2, NANOG, and ACTB protein expression by western blotting with antibodies against each protein. Cdx2-
inducible ESC line was cultured for 0, 0.5, 1, 2, 3, 5, and 7 days in the Dox condition.
(J) ChIP-qPCR analysis for POU5F1 binding on its target genes in Cdx2-inducible ESCs. Primers flanking a gene desert region in chromosome 3 were used as
a negative control. The relative enrichment of POU5F1 binding was represented as a fold change. Error bars: ±SEM.
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(A) Relative abundance of genes with TFBS (transcription factor binding sites) in distal (0.3–15 Kb upstream and downstream from the TSS) and proximal (<300 bp
upstream and downstream from the TSS) portions of the promoter, as well as genes with chromatin modifications within 1 Kb from the TSS, in sets of genes
upregulated or downregulated (>2-fold changes of gene expression, but at least 200 genes in each group) by the induction of TFs (shown in the first column),
compared to the control set of unaffected genes. CDX2, POU5F1, SOX2, NANOG, STAT3, and SMAD1 bind mostly to distal sites, and the number of binding
sites in proximal promoters was not sufficient, and thus was not included for analysis. TFs are ordered according to the expression level of endogenous genes
in ESCs from abundant to those that are not expressed in ESCs based on published RNA-Seq data (Table S11; Cloonan et al., 2008). Cells are color-coded based
on the overrepresentation or underrepresentation of genes with TFBS compared to the control group of genes that did not respond to the induction of TF (<1.25-
fold change). Cells are not color-coded if the difference in the proportion of genes with TFBS is not statistically significant. Data on TFBS and chromatin modi-
fications (Chr) in promoters of genes were compiled from our ChIP-Seq experiment with CDX2 (Figure 5) and published data (H3K4me3 and H3K27me3 data from
Mikkelsen et al. [2007]; the rest of the data from Chen et al. [2008]). K4me3 indicates genes marked with H3K4me3; K4K27me3 indicates genes marked with both
H3K4me3 and H3K27me3 (‘‘bivalent domains’’).
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Mass spectrometric analysis of the immunoprecipitated protein
complex revealed a number of proteins matched by multiple
peptides (Figure S9). Based on the relatively high number of
peptide matches, the following protein groups are likely to be
the components of CDX2 complex: (1) NuRD (nucleosomal re-
modeling and histone deacetylase) complex, including HDAC1,
MBD3, and CHD4 (Denslow and Wade, 2007); (2) SALL4; (3)
PARP1; and (4) KPNB1 (Importin-1-beta), a protein known for
its function in nuclear transport (Lange et al., 2007).
The presence of HDAC1, SALL4, and KPNB1 in the CDX2-
associated complex was validated by IP-western blotting with
antibodies against these proteins (Figure 6C). To test whether
SALL4 is a component of NuRD-CDX2 complex, we carried
out a reverse-IP assay with antibodies against HDAC1 and
SALL4, respectively (Figure 6D). Western blotting results
confirmed the interaction between SALL4 and HDAC1 both in
the absence of CDX2 (Dox+) and in the presence of CDX2
(Dox). By contrast, UBF, used as a control, was present in the
HDAC1-IP sample but absent in the SALL4-IP sample. HDAC1
and SALL4 were present at similar levels in the nuclear extract
from Dox+ and Dox cells. Taken together, these data indicate
that CDX2 associates with NuRD and SALL4 in Cdx2-induced
ESCs.
Compendium Analysis of TF-Binding Sites in Genes
Affected by the Induction of TFs
To gain further information about global TF regulatory networks in
ESCs, we extended the analysis done for CDX2 to the other 32
TFs that caused significant changes in the expression of >150
genes (Figure 3B). Gene sets that were up- or downregulated
by each induced TF were examined for overrepresentation of
genes with binding sites of various TFs and with various
chromatin modifications based on ChIP-Seq data published for
ESCs with sufficient tag numbers (Figure 7A; Table S10; Chen
et al., 2008; Mikkelsen et al., 2007). The compendium analysis re-
vealed three global features of gene regulatory networks in ESCs.
First, like CDX2, lists of genes downregulated by the induction
of at least 15 other TFs were enriched for those with binding sites
for pTFs (i.e., POU5F1, SOX2, NANOG, STAT3, and SMAD1)
(Figure 7A; Figures S10 and S11). To confirm this finding, we
did a similar analysis with TF binding sites identified with ChIP-
chip methodology (Kim et al., 2008). The results (Figure S12)
were consistent with our previous analysis and showed that
pTFs include three additional TFs: Nr0b1 (Dax1), Nac1, and
Zfp281. pTF targets include genes that are commonly associ-
ated with ESC pluripotency: Nr5a2, Fgf4, Lrrc2, Foxd3, Klf2,
Nr0b1, Tcea3, Tdgf1, Zfp42, Aire, Phc1, Mycn, Sox2, Jmjd1a,
Jarid2, Nanog, Spp1, Myc, Nodal, Dppa3, Trim24, Zic3, Sall4,
Dppa5a, Rest, Lefty1, Lefty2, Mybl2, and Pou5f1 (see
Figure S11 for a full gene list).Second, genes with binding sites for the polycomb gene
Suz12 were enriched in the lists of genes that responded to the
induction of nearly all the TFs. We looked at the genes previously
identified as having ‘‘bivalent’’ chromatin domains in their
promoters, characterized by a combination of H3K4me3 and
H3K27me3 marks (Azuara et al., 2006; Bernstein et al., 2006;
Roh et al., 2006), because it is known that Suz12 is associated
with bivalent domains (Boyer et al., 2006; Lee et al., 2006).
With published data (Table S10; Mikkelsen et al., 2007), we found
that both genes upregulated and genes downregulated by nearly
all the TF inductions were enriched for those with bivalent
domains (Figure 7A). Previously, a bivalent domain has been
attributed to genes that are ‘‘poised’’ or ‘‘primed,’’ indicating
that the expression levels of these genes are low or none, but
that the gene is ready to be activated immediately (Azuara
et al., 2006; Bernstein et al., 2006). Therefore, it is not unusual
to see that upregulated genes fall into the category of genes
marked with bivalent domains. However, current models do
not anticipate that many of the genes that are downregulated
also fall into bivalent domains. Intrigued by the downregulation
of genes with bivalent domains, we first searched for genes
with relatively high expression in ESCs (>30% of maximum
expression level) in our earlier compendium microarray data of
differentiating ESCs (Aiba et al., 2009) and found 460 such genes
with bivalent domains (Figure S13). Among them, 280 genes
were downregulated more than 2-fold after induction of some
TFs (Figure S13). To validate whether these genes were indeed
downregulated during differentiation, we examined the changes
of expression by microarray and qRT-PCR for five genes from
this list during ESC differentiation into trophoblasts. In all genes
examined, expression was indeed downregulated by hundreds
of folds (Figure S13E).
Third, genes with binding sites of MYC, MYCN, E2F, and ZFX in
the proximal regulatory regions were strongly depleted in both
up- and downregulated gene lists in almost all the TF-induced
ESCs (Figure 7A). Similar results were obtained with MYC binding
sites from another report (Figure S12; Kim et al., 2008). Some of
these genes are already maximally expressed and therefore
cannot be upregulated further. It is not clear why expression of
these genes is not effectively downregulated after manipulation
of TFs. In any case, binding sites of MYC, MYCN, E2F, and ZFX
seem to mark genes that are refractory to the induction of TFs.
DISCUSSION
Initial analyses of 3% (50) of all TF genes have provided
a glimpse of the structure and dynamics of global gene regula-
tory networks as well as proof-of-principle that this experimental
system provides potentially universal tools and resources for
gain-of-function analyses of transcription factors (TFs) in vitro
and in vivo (Figure 7B). The ESC lines reported here will be freely(B) Potential applications of TF-inducible ESC Bank, for which a proof-of-principle has been shown in this paper.
(C) A model for ESCs in undifferentiated state. Cdx2-target genes (red boxes, e.g., Hoxa7; Figure 5F) are not actively transcribed. Pluripotency-associated tran-
scription factors (pTFs, e.g., POU5F1, SOX2, and NANOG) are present and bind to the regulatory regions of pTF-target genes (blue boxes), resulting in the active
transcription of these genes. pTF-target genes include genes encoding pTFs, which thus form positive feedback loops and maintain the levels of pTFs.
(D) A model for ESCs in the early phase after the forced induction of Cdx2. CDX2 protein binds directly to the regulatory region of Cdx2-target genes, which begin
to be actively transcribed. CDX2 suppresses the binding of pTFs to the regulatory regions of pTF-target genes and shut downs the transcription of pTF-target
genes.
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accumulation and comparison of a variety of information on
these standardized ESCs.
Some Notable Biological Findings from the Study
One of the striking observations is the difference between TFs in
terms of their relative impact on the ES transcriptome (Figure 3).
Some TFs can cause a huge perturbation, whereas others cause
almost no change. Of particular interest, TFs with a high impact
on the transcriptome include the four TFs (Klf4, Pou5f1, Sox2,
and Myc) that have been successfully used to convert fibroblast
cells into iPS cells (Takahashi and Yamanaka, 2006). This may
indicate that formation of iPS cells correlates with the capacity
of these TFs to perturb the transcriptome dramatically. Overall,
the systematic study of TFs reveals important behaviors that
would not be immediately evident in traditional phenotype-
driven screens.
Interestingly, TFs that are known to function in late lineage
specification (Ascl1, Ascl2, Myod1, Sox9, and Sfpi1) induced
expression profiles that overlapped substantially with late-stage
differentiated cells within 48 hr of TF overexpression (Figures 2C
and 2D). The data suggest that undifferentiated ESCs may be in
a permissive or susceptible state, in which forced induction of
single TFs can make relevant changes in the transcriptome,
regardless of whether usual TF partners or regulatory context
are in place. These data seem to be consistent with the idea
that the chromatin of ESCs is less restricted and more open,
so changes of TF level alone can cause critical transcriptome
changes (Meshorer and Misteli, 2006; Niwa et al., 2005; Silva
and Smith, 2008). Whether or not this feature is specific to
ESCs should be further tested by examining other cell types,
such as fibroblasts.
There are nevertheless categories of genes whose response is
modulated by structural or epigenetic cues. For example, genes
upregulated by various TFs are enriched in genes with bivalent
domains (H3K4me3+H3K27me3) and depleted in genes with
binding sites of MYC, MYCN, E2F, and ZFX in promoters
(Figure 7A). The same trend was observed for genes that were
downregulated by these TFs, although the number of genes
was much smaller (only up to 10% of all 3000 genes with biva-
lent domains). Thus, genes with bivalent domains may form
a dynamic network that can be rapidly up- or downregulated by
changes in expression of TFs, whereas genes with binding sites
of MYC, MYCN, E2F, and ZFX in promoters tend to maintain
the status quo in their expression level responses to TF changes.
Modes of Gene Regulation by CDX2
By current thinking, the maintenance of expression of ES-
specific genes is governed by the transcriptional network of
pTFs (especially, Pou5f1, Sox2, and Nanog) (Boyer et al., 2005;
Chen et al., 2008; Jaenisch and Young, 2008; Kim et al., 2008;
Loh et al., 2006). These genes form a positive feedback loop to
maintain their own expression levels while at the same time regu-
lating other ESC-specific genes (Figure 7C). Our data imply that
CDX2 induction causes the widespread downregulation of pTF-
target genes. However, the data further indicate that CDX2 does
not inactivate the transcription of pTFs by directly binding to their
regulatory regions; rather, CDX2 interferes with the binding of
pTFs to the regulatory regions of pTF-target genes (Figure 7D).430 Cell Stem Cell 5, 420–433, October 2, 2009 ª2009 Elsevier Inc.Such an effect at the protein complex level would facilitate swift
adaptation for ESCs to begin or commit to differentiation path-
ways. Because at least some of the pTFs (POU5F1, SOX2, and
NANOG) are also pTF targets, the protein levels of POU5F1,
SOX2, and NANOG would eventually decline, and the differenti-
ation process would pass a point of no return and become
irreversible.
It has been well established that NuRD is involved in gene tran-
scriptional repression and chromatin remodeling (Denslow and
Wade, 2007). Therefore, NuRD could play a major role in inter-
fering with the bindings of pTFs to their targets. This notion is
consistent with previous findings that ESCs lacking MBD3, one
of the key components of the NuRD complex, cannot differen-
tiate and remain undifferentiated even under differentiation-
inducing conditions (Kaji et al., 2006). Indeed, our mass-
spectrometry analysis of CDX2-associated protein complex
identified the presence of MBD3. However, the exact mecha-
nism of NuRD actions remains unknown. For example, CDX2
may recruit NuRD to the pTFs, resulting in inactivation of the
pTFs. Alternatively, CDX2 may compete with the pTFs (particu-
larly POU5F1; Niwa et al., 2005) for the binding of NuRD; it has
been shown that pTFs interact with the NuRD in the absence
of CDX2 in undifferentiated ESCs (Liang et al., 2008; Wang
et al., 2006). The SALL4-CDX2 association revealed in this study
may also be significant, because Sall4 is required to maintain
ESC pluripotency and is important for early embryonic cell-fate
decisions (Kim et al., 2008; Lim et al., 2008; Yang et al., 2008;
Zhou et al., 2007).
Hints of the Mechanism of TF-Mediated Global
Downregulation of ES-Specific Genes
We note at least three possible groups of TFs based on their
ability to downregulate the pTF-target genes. A first group of
TFs shows no strong effects on pTF-target genes. A second
group of TFs is exemplified by CDX2 and includes Esx1, Dlx3,
Gata3, Ascl1, Sox9, Sfpi1, Mef2c, Nr2f2, and Myod1 (Figure 7A).
These TFs are not expressed or are expressed at low levels in
undifferentiated ESCs. The forced induction of these TFs down-
regulates direct target genes of pTFs, possibly through the same
mechanism as CDX2. This is reasonable, because the differenti-
ation of ESCs requires the downregulation of ES-specific genes,
particularly genes involved in the maintenance of pluripotency of
ESCs. A third group of TFs includes Pou5f1, Sox2, and Klf4,
which are expressed relatively highly in undifferentiated ESCs,
but still show a significant perturbation of the global transcrip-
tome after a moderate increase in their expression levels (Fig-
ure 7A). Because it has been shown that pTFs (e.g., POU5F1,
SOX2, and NANOG) form a protein complex (Liang et al., 2008;
Wang et al., 2006), overexpression of one component could
distort the stoichiometry of this complex, possibly resulting in
a reduced amount of the effective protein complex and leading
to the downregulation of direct target genes of pTFs. As an
additional consistent observation, it has been reported that
Klf4 regulates downstream genes in a synergistic manner with
Pou5f1 and Sox2 (Nakatake et al., 2006). This model rationalizes
the fact that both Pou5f1 overexpression and repression can
downregulate pTF-target genes, as indicated by the fact
that both of them could cause a reduction in effective pTF
complexes. This peculiar dose-response pattern of gene
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Systems Biology of ESCsexpression has previously been called ‘‘squelching’’ (Scholer
et al., 1991), but has also been called ‘‘bell-shaped’’ or ‘‘inverse
bell-shaped’’ based on the behavior of a large number of genes
regulated by Pou5f1 in DNA microarray studies (Matoba et al.,
2006).
Concluding Remarks
At the outset of this project, we reasoned that analyses of a large
number of TFs might be requisite to explore global TF network(s)
beyond the core transcriptional network of Pou5f1, Sox2, and
Nanog. After analyzing large-scale transcriptome changes
induced by 50 TFs, the core network remains one of the most
conspicuous features of gene expression regulation in ESCs.
These data thus reinforce the current paradigm that Pou5f1/
Sox2/Nanog are the key regulators maintaining the pluripotent
undifferentiated state of ESCs (Jaenisch and Young, 2008;
Niwa, 2007; Silva and Smith, 2008). Furthermore, our data
have revealed that suppression of pTF activity, which causes
widespread downregulation of ES-specific genes, is an early
step of TF-induced ESC differentiation. Further mining of the
results reported here may provide additional inferences about
relevant gene regulatory networks. Carrying out similar experi-
ments for a larger number of regulatory proteins—and ideally
all 1600–2000 TFs and additional signaling proteins—should
give increasingly complete information to help infer the cyber-
netic networks in mammalian cells.
EXPERIMENTAL PROCEDURES
Establishment of TF-Inducible ESCs
MC1 mouse ESCs derived from 129S6/SvEvTac were cultured in DMEM with
15% FBS and LIF on feeder cells. Cells were electroporated with linearized
pMWROSATcH and selected by hygromycin B. Knock-in for ROSA-TET locus
in ES[MC1R(20)] cells was confirmed by Southern blotting. For exchange
vectors, PCR-amplified ORFs were subcloned into pZhcSfi that was modified
to express His6-FLAG-tagged protein and puromycin-resistant gene.
ES[MC1R(20)] cells (passage 17) cultured on feeder cells were cotransfected
with a sequence-verified exchange vector and pCAGGS-Cre and selected
by puromycin in the presence of Dox. Isolated clones were tested for Venus
expression, hygromycin B susceptibility, transgene RNA expression, genotyp-
ing for Cre-mediated integration, karyotyping, western blotting with FLAG
antibody, and mycoplasma contamination (Supplemental Data). Further
details about the ESC lines and how to obtain them can be found in the project
website (http://esbank.nia.nih.gov/).
Transgene Induction and DNA Microarray
ESCs (passage 25) were cultured in the standard LIF+ medium on a gelatin-
coated dish through the experiments. Dox was removed through washing
three times with PBS at 3 hr intervals and total RNA was isolated by TRIzol
(Invitrogen) after 2 days. All procedures for each ES line were done in two inde-
pendent replications (Figure S14). Cy3-CTP-labeled sample targets were
prepared with total RNA by Low RNA Input Fluorescent Linear Amplification
Kit (Agilent). A Cy5-CTP-labeled reference target was produced from mixture
of Stratagene Universal Mouse Reference RNA and MC1 cells RNA. Targets
were hybridized to the NIA Mouse 44K Microarray v3.0 (Agilent, design ID
015087) (Carter et al., 2005). Slides were scanned with Agilent DNA Microarray
Scanner. All DNA microarray data are available in Table S1.
Immunoprecipitation
CDX2 complexes were purified with anti-FLAG M2 affinity gel and proteins
were eluted by 3XFLAG peptide for mass spectrum analysis or Laemmli’s
sample buffer for western blotting.CChIP and Sequencing Analysis
Cross-linked chromatin from Cdx2-expressed cells was fragmented by soni-
cation and incubated with anti-FLAG M2 affinity gel. The immunoprecipitate
was eluted and reverse cross-linked. Sequence sample preparation, Cluster
generation on Cluster Station (Illumina), and sequencing by Genome Analyzer
II (Illumina) were performed according to Illumina’s manuals. See details in
Supplemental Experimental Procedures. ChIP-Seq data are available at
GEO/NCBI (GSE16375).
ACCESSION NUMBERS
All DNA microarray data are available at GEO/NCBI (http://www.ncbi.nlm.nih.
gov/geo/; GSE16375) and at NIA Array Analysis software (Sharov et al., 2005;
http://lgsun.grc.nia.nih.gov/ANOVA/).
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Supplemental Data include Supplemental Experimental Procedures, 16 fig-
ures, and 12 tables and can be found with this article online at http://www.
cell.com/cell-stem-cell/supplemental/S1934-5909(09)00348-8.
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